Dietary supplements and disease prevention - a global overview. (Q30251418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

review article

1 reference

title

Dietary supplements and disease prevention - a global overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

2

JoAnn E Manson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

Alice H. Lichtenstein

series ordinal

3

object named as

Alice H Lichtenstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Howard D Sesso

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

publication date

6 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

4 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

407-420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Malnutrition and quality of life in older people: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Dietary supplement use in the United States, 2003-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Factors affecting the use of dietary supplements by Korean adults: data from the Korean National Health and Nutrition Examination Survey III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Opposites don't attract: high spouse concordance for dietary supplement use in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Consistency of vitamin and/or mineral supplement use and demographic, lifestyle and health-status predictors: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Sociodemographic, lifestyle and dietary correlates of dietary supplement use in a large sample of French adults: results from the NutriNet-Santé cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium plus vitamin D supplementation and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium plus vitamin D supplementation and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Update on the Vitamin D and OmegA-3 trial (VITAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

n-3 fatty acids in patients with multiple cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

n-3 fatty acids and cardiovascular events after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Selenium and Vitamin E for Prostate Cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A trial of calcium and vitamin D for the prevention of colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Lung Cancer Chemoprevention: A Randomized, Double-Blind Trial in Linxian, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium/vitamin D supplementation and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Prevention of hypertension and cardiovascular diseases: a comparison of lifestyle factors in Westerners and East Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Chronic hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Optimizing bone health in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium intake, calcium bioavailability and bone health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D3 and calcium to prevent hip fractures in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial--the OSTPRE-FPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A pooled analysis of vitamin D dose requirements for fracture prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Prevention of rickets and vitamin D deficiency in infants, children, and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D in the healthy European paediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D: An overview of vitamin D status and intake in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D requirement and setting recommendation levels: long-term perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized trial of beta carotene and age-related cataract in US physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E and age-related cataract in a randomized trial of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Lutein Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E and age-related macular degeneration in a randomized trial of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Daily Zinc but Not Multivitamin Supplementation Reduces Diarrhea and Upper Respiratory Infections in Tanzanian Infants: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Economic burden of neural tube defects and impact of prevention with folic acid: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Factors contributing to the success of folic acid public health campaigns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Monitoring of the folic acid supplementation program in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Socioeconomic, lifestyle and dietary factors associated with dietary supplement use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Prenatal folic acid and risk of asthma in children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Global iodine nutrition: Where do we stand in 2013?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Nutrient Status Assessment in Individuals and Populations for Healthy Aging-Statement from an Expert Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A major role for cardiovascular burden in age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin B12 and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized trial of vitamin E supplementation and cognitive function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of low dose ω-3 poly unsaturated fatty acids on cognitive status among older people: a double-blind randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of vitamin D supplementation on cognitive and emotional functioning in young adults--a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Long-term multivitamin supplementation and cognitive function in men: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Preventing depression: a global priority

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of long-term supplementation with folic acid and B vitamins on risk of depression in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Efficacy of vitamin D supplementation in depression in adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Acute mood but not cognitive improvements following administration of a single multivitamin and mineral supplement in healthy women aged 50 and above: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

The effect of multivitamin supplementation on mood and stress in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Maternal lifestyle and environmental risk factors for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of Cholecalciferol Supplementation During Winter Months in Patients With Hypertension: A Randomized, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A comparison of micronutrient inadequacy and risk of high micronutrient intakes among vitamin and mineral supplement users and nonusers in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Sociodemographic and health behaviour factors among dietary supplement and natural remedy users

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin D research and clinical practice: at a crossroads

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin E supplementation and cardiovascular events in high-risk patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Oral zinc in macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Evaluation of vitamin A toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effects of vitamins E and C combined with β-carotene on cognitive function in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Vitamins B12, B6, and Folic Acid for Onset of Depressive Symptoms in Older Men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

DSM-V Changes for Autism Spectrum Disorder (ASD): Implications for Diagnosis, Management, and Care Coordination for Children With ASDs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRENDO.2016.54

Daily oral iron supplementation during pregnancy

31 March 2020

1 reference

12 December 2020

Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.

1 reference

12 December 2020

Intermittent iron supplementation for improving nutrition and development in children under 12 years of age

1 reference

12 December 2020

Effects and safety of periconceptional folate supplementation for preventing birth defects

1 reference

12 December 2020

Micronutrient supplementation for children with HIV infection

1 reference

12 December 2020

Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial

1 reference

12 December 2020

Omega-3 fatty acids for intermittent claudication

1 reference

12 December 2020

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents

1 reference

12 December 2020

Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial

1 reference

12 December 2020

Vitamin D supplementation for prevention of cancer in adults

1 reference

12 December 2020

Omega-3 fatty acids supplementation for autism spectrum disorders (ASD)

1 reference

12 December 2020

Vitamin D supplementation for women during pregnancy

1 reference

12 December 2020

International Food Policy Research Institute. 2014. Washington, DC: Global Nutrition Report 2014: actions and accountability to accelerate the world's progress on nutrition

1 reference

12 December 2020

Dietary advice for the prevention of type 2 diabetes mellitus in adults

1 reference

12 December 2020

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

1 reference

12 December 2020

Interventions for the prevention of nutritional rickets in term born children

1 reference

12 December 2020

Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women

1 reference

12 December 2020

Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less

1 reference

12 December 2020

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2016.54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27150288 AND SRC:MED&resulttype=core&format=json

4 April 2020

1 reference